CogMe

Company Overview

Snapshot

Founded in December 2020 by Liat Feinberg and Ilan Ben Oren, CogMe operates with 1–10 employees. The company has raised $1.4M across one funding round from 4 investors. In January 2021, MindUP invested in CogMe as its 13th portfolio company.

Business overview

CogMe develops a holistic AI platform designed to prevent and detect cognitive and physiological decline in at-risk older adults. The company's core technology leverages machine learning and deep learning methodologies to analyze cognitive, physiological, and activity indicators, providing actionable data for personalized care plans. CogMe's expert system applies clinical guidelines to predict, detect, and intervene to prevent decline in both inpatient and outpatient settings, initially focusing on delirium. It serves the healthcare market, specifically targeting patients and providers within the digital healthcare, medical decision support, and seniors segments.

Strategic signal

In January 2021, MindUP strategically invested in CogMe, highlighting the startup's potential as a holistic solution for detecting and preventing delirium. This investment signals strong validation for CogMe's AI-driven approach to addressing critical health challenges in older adults, positioning the company for further development and market penetration in the digital health sector.

Company Intelligence Q&A

When was CogMe founded and by whom?

CogMe was founded in December 2020 by Liat Feinberg and Ilan Ben Oren.

How much capital has CogMe raised?

CogMe has raised a total of $1.4M in funding.

Which investors participated in CogMe's funding round?

In January 2021, CogMe received investment from MindUP, IBM Ventures, Medtronic, and Pitango HealthTech.

What is the current product stage of CogMe's solution?

CogMe's solution is currently in the clinical trial stage, focusing on preventing and detecting cognitive and physiological decline in at-risk older adults.